Skip to main content
Clinical Trials/NCT01807403
NCT01807403
Completed
Phase 3

Comparison of the Efficacy of Subthalamic Nucleus, Caudate Nucleus and Nucleus Accumbens Electric Stimulation in Severe and Resistant Obsessive-compulsive Disorder.

Assistance Publique - Hôpitaux de Paris1 site in 1 country8 target enrollmentOctober 2010

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Obsessive-Compulsive Disorder
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
8
Locations
1
Primary Endpoint
Severity of symptoms after each phase
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Deep brain stimulation (DBS) has been proposed for severe and resistant obsessive-compulsive disorder. This electrical stimulation has been tested on, and shown to be effective at, different targets (subthalamic nucleus, caudate nucleus & nucleus accumbens). However, the efficacies of each target have never been compared directly.

This protocol aims to do so, with the hypothesis that subthalamic (STN) stimulation will be more efficacious.

Detailed Description

Deep brain stimulation has been proposed for severe and resistant obsessive-compulsive disorder (OCD). This electrical stimulation has been tested on, and shown to be effective at, different targets (subthalamic nucleus, caudate nucleus \& nucleus accumbens). However, the efficacies of each target have never been compared directly. Therefore, bilateral subthalamic and caudate electrodes will be implanted in severe OCD patients. Efficacy of stimulation at the different targets will be assessed using a double-blind randomised crossover design.

Registry
clinicaltrials.gov
Start Date
October 2010
End Date
February 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Severity of symptoms after each phase

Time Frame: 3 months

Severity as measured by the Yale-Brown Obsession and Compulsion scale

Secondary Outcomes

  • Severity of symptoms after each phase(14 months)

Study Sites (1)

Loading locations...

Similar Trials